Discount sale is live
Logo
Infectious Disease Therapeutics Market
  2. / Market Insights
  3. Table of Content - Infectious Disease Therapeutics Market Analysis
all report title image

Infectious Disease Therapeutics Market, By Therapeutic Type (Antibiotics, Antivirals, Antifungals, Vaccines, and Others), By Disease Indication (Respiratory Infections, Sexually Transmitted Infections (STIs), Bloodborne Infections, Gastrointestinal Infections, and Others), By Route of Administration (Oral, Parenteral, Topical, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

  • Published In : 22 Oct, 2025
  • Code : CMI1658
  • Formats :
      Excel and PDF
  • Industry : Pharmaceutical
  • 歴史的範囲: 2020 - 2024
  • 歴史的範囲: 2020 - 2024
Ingographics Image
N/A

Table of Contents

  1. Research Objectives and Assumptions

    • Research Objectives

    • Assumptions

    • Abbreviations

  2. Market Preview

    • Report Description

      • Market Definition and Scope

    • Executive Summary

      • Market Snapshot, By Therapeutic Type

      • Market Snapshot, By Disease Indication

      • Market Snapshot, By Route of Administration

      • Market Snapshot, By Region

    • Coherent Opportunity Map (COM)

  3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics

      • Drivers

      • Restraints

      • Market Opportunities

    • Impact Analysis

    • Recent Product Launches

    • Epidemiology

    • Merger, Acquisition, and Collaboration

    • Regulatory Scenario

    • Key Developments

    • PEST Analysis

    • Partnership Scenario

    • Brand and Pricing Analysis

    • Distributors Landscape

    • Porters Analysis

    • Technological Advancements

    • Key Developments

    • Market Trend

    • Future Prospective

    • Top Market Players by Revenue

  4. Infectious Disease Therapeutics Market By Therapeutic Type, 2025–2032, (US$ Billion)

    • Introduction

      • Market Share Analysis, 2025 and 2032 (%)

      • Y-o-Y Growth Analysis, 2021–2032

      • Segment Trends

    • Antibiotics

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)

    • Antivirals

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)

    • Antifungals

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)

    • Vaccines

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)

    • Others

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)

  5. Infectious Disease Therapeutics Market By Disease Indication, 2025-2032, (US$ Billion)

    • Introduction

      • Market Share Analysis, 2025 and 2032 (%)

      • Y-o-Y Growth Analysis, 2021–2032

      • Segment Trends

    • Respiratory Infections

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)

    • Sexually Transmitted Infections (STIs)

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)

    • Bloodborne Infections

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)

    • Gastrointestinal Infections

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)

    • Others

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)

  6. Infectious Disease Therapeutics Market By Route of Administration, 2025-2032, (US$ Billion)

    • Introduction

      • Market Share Analysis, 2025 and 2032 (%)

      • Y-o-Y Growth Analysis, 2021–2032

      • Segment Trends

    • Oral

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)

    • Parental

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)

    • Topical

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)

    • Others

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)

  7. Infectious Disease Therapeutics Market By Region, 2025-2032, (US$ Billion)

    • Introduction

      • Market Share Analysis, By Region, 2025 and 2032 (%)

      • Y-o-Y Growth Analysis, For Regions, 2021–2032

      • Regional Trends

    • North America

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Type, 2025-2032, (US$ Billion)

      • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2025-2032, (US$ Billion)

      • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2025-2032, (US$ Billion)

      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2025-2032, (US$ Billion)

        • U.S.

        • Canada

    • Latin America

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Type, 2025-2032, (US$ Billion)

      • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2025-2032, (US$ Billion)

      • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2025-2032, (US$ Billion)

      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2025-2032, (US$ Billion)

        • Brazil

        • Mexico

        • Argentina

        • Rest of Latin America

    • Europe

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Type, 2025-2032, (US$ Billion)

      • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2025-2032, (US$ Billion)

      • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2025-2032, (US$ Billion)

      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2025-2032, (US$ Billion)

        • U.K.

        • Germany

        • Italy

        • France

        • Spain

        • Russia

        • Benelux

        • Denmark

        • Norway

        • Sweden

        • Rest of Europe

    • Asia Pacific

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Type, 2025-2032, (US$ Billion)

      • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2025-2032, (US$ Billion)

      • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2025-2032, (US$ Billion)

      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2025-2032, (US$ Billion)

        • China

        • Taiwan

        • India

        • Japan

        • Indonesia

        • Malaysia

        • Philippines

        • Singapore

        • Australia

        • South Korea

        • Rest of Asia Pacific

o Middle East & Africa

  • Introduction

  • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Type, 2025-2032, (US$ Billion)

  • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2025-2032, (US$ Billion)

  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2025-2032, (US$ Billion)

  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2025-2032, (US$ Billion)

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • UAE

    • Israel

    • South Africa

    • North Africa

    • Central Africa

    • Rest of the Middle East

  1. Competitive Landscape

    • Pfizer Inc.

      • Company Highlights

      • Product Portfolio

      • Key Highlights

      • Financial Performance

      • Market Strategies

    • GSK plc

      • Company Highlights

      • Product Portfolio

      • Key Highlights

      • Financial Performance

      • Market Strategies

    • Merck & Co., Inc.

      • Company Highlights

      • Product Portfolio

      • Key Highlights

      • Financial Performance

      • Market Strategies

    • Johnson & Johnson

      • Company Highlights

      • Product Portfolio

      • Key Highlights

      • Financial Performance

      • Market Strategies

    • Roche Holding AG

      • Company Highlights

      • Product Portfolio

      • Key Highlights

      • Financial Performance

      • Market Strategies

    • Novartis AG

      • Company Highlights

      • Product Portfolio

      • Key Highlights

      • Financial Performance

      • Market Strategies

    • Sanofi S.A.

      • Company Highlights

      • Product Portfolio

      • Key Highlights

      • Financial Performance

      • Market Strategies

    • Bristol-Myers Squibb Company

      • Company Highlights

      • Product Portfolio

      • Key Highlights

      • Financial Performance

      • Market Strategies

    • AbbVie Inc.

      • Company Highlights

      • Product Portfolio

      • Key Highlights

      • Financial Performance

      • Market Strategies

    • Bayer AG

      • Company Highlights

      • Product Portfolio

      • Key Highlights

      • Financial Performance

      • Market Strategies

    • Takeda Pharmaceutical Company Limited.

      • Company Highlights

      • Product Portfolio

      • Key Highlights

      • Financial Performance

      • Market Strategies

    • AstraZeneca plc

      • Company Highlights

      • Product Portfolio

      • Key Highlights

      • Financial Performance

      • Market Strategies

  2. Section

    • Research Methodology

    • About Us

  • Need a Custom Report?

    We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

    Customize Now
Logo

Credibility and Certifications

ESOMAR
DUNS Registered

860519526

Clutch
Credibility and Certification
Credibility and Certification

9001:2015

Credibility and Certification

27001:2022

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2025 Coherent Market Insights Pvt Ltd. All Rights Reserved.